Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Volatile week - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Aug 25, 2007

    Volatile week

    Volatility was the order of the week with markets witnessing curt crashes and swift recoveries as the focus shifted to domestic factors and in particular, to the fate of the UPA government in its confrontation with the left parties over the Indo-US civil nuclear agreement. The bulls, however, had the last say with markets ending the week with a gain of 2%.

    The tug of war between the bulls and bears led to indices oscillating between the positive and the negative territory for the entire week. Unlike previous week, when global cues dictated the markets, it was the domestic politics that gnawed at investors this time around. The week began on a positive note with BSE-Sensex advancing close to 300 points, tracking strong global cues. The recovery was led by bank and metal stocks, which were butchered during the previous week. The joy was, however, short-lived as bears made a comeback on Tuesday, unwinding all the gains registered a day earlier as the speculations of withdrawal of support by the Left parties to the government became rife. Bulls were back with a vengeance on Wednesday as markets gained close to 2% led by capital goods and metal stocks. The markets remained extremely volatile on Thursday, closing marginally in the red after gaining more than 2% in early trades. After 4 volatile trading sessions, the sentiments turned positive on Friday, as the Left clarified that they did not want to destabilize the government. Buying in auto, cement, capital goods and FMCG stocks led to Sensex closing with a gain of 283 points (or 2%).

    On the institutional activity front, between 10th and 16th August, while Foreign Institutional Investors (FIIs) sold equities worth Rs 35 bn, domestic mutual funds emerged as net buyers to the tune of Rs 16 bn.

    (Rs m) MFs FIIs Total
    17-Aug 8,783 (32,427) (23,644)
    20-Aug 1,523 928 2,451
    21-Aug (165) (98) (263)
    22-Aug 3,210 (6,681) (3,471)
    23-Aug 3,091 3,304 6,395
    Total 16,442 (34,974) (18,532)

    On the sectoral indices front, the BSE Healthcare and the BSE IT index ended with a loss of 2% each, while the BSE Metal and the FMCG index gained 5% and 4% respectively. Buying in metal stocks was aided by the recovery in metal prices on the London Metal Exchange (LME). Small-caps and Mid-caps, however, refused to participate in the recovery losing 2% each during the week.

    Index As on August 17 As on August 24 % Change
    BSE IT 4,500 4,408 -2.0%
    BSE SMLCAP 7,695 7,522 -2.2%
    BSE OIL AND GAS 7,427 7,517 1.2%
    BSE HEALTHCARE 3,487 3,424 -1.8%
    BSE AUTO 4,561 4,569 0.2%
    BSE PSU 6,543 6,626 1.3%
    BSE MIDCAP 6,259 6,190 -1.1%
    BSE FMCG 1,812 1,878 3.7%
    BSE BANKEX 7,351 7,315 -0.5%
    BSE METAL 9,812 10,277 4.7%

    Now let us have a look at some of the key stock/sector specific developments during the week:

    Cement stocks closed firm for the week with Ambuja Cements and India featuring among the key gainers (each up 7%). Switzerland's Holcim has announced a public takeover offer for another 20% of the share capital of Ambuja Cements in a bid worth around US$ 1.1 bn. In case the public offer is accepted in full, Holcim's stake in Ambuja will rise to more than 56%. Holcim Mauritius, an indirect wholly owned subsidiary of Holcim (Europe), the world's second-largest cement maker, had over a period of time, directly and indirectly has acquired 32% stake in the company. While the merger with Ambuja Cement Eastern has provided the company with a presence in the eastern markets, Holcim's expertise will benefit it in the long term. The company has outlined investment outlay of Rs 35 bn to increase its capacity from the current 16 MT to 22 MT by 2009 and also to increase its clinker capacity.

    Top gainers during the week (BSE A)
    Company Price on
    Aug 17 (Rs)
    Price on
    Aug 24 (Rs)
    H/L (Rs)
    BSE SENSEX 14,142 14,425 2.0% 15,869 / 11,297
    S&P CNX NIFTY 4,108 4,191 2.0% 4,648 / 3,305
    CHAMBAL FERT. 37 47 25.0% 52 / 30
    BHEL 1,559 1,750 12.3% 1899 / 970
    STERLITE IND. 517 576 11.5% 682 / 398
    BHARTI AIRTEL 795 866 9.0% 960 / 382
    TATA TEA 666 719 8.1% 990 / 58

    Energy stocks closed mixed for the week with Cairn India (ended 4% up) and ONGC (up 3%) featuring among the major gainers, while Castrol and Petronet LNG (each down 4%) ended in the red. As per a leading business daily, Reliance Industries (RIL) has reported its discontent with the current policy of maintaining retail fuel prices low and compensating PSU oil marketing companies for their under-recoveries with the subsidies and oil bonds. As a fall out, RIL will not open the required number of outlets in remote and low-service areas. Around 11% of the company's total outlets are required to be in such areas. The company is of the view that the outlets in question can be viable only when profit generated elsewhere from market-determined prices can be used to cross-subsidise them. RIL plans to meet its obligations when market-determined prices prevail in the future. It must be noted that the upstream (exploration and production) segment of the hydrocarbon chain is more crucial for the country. Hence changes in retailing plans will not dent the fundamentals of the sector.

    Top losers during the week (BSE A)
    Company Price on
    Aug 17 (Rs)
    Price on
    Aug 24 (Rs)
    H/L (Rs)
    BONGAIGAON REFN. 56 49 -12.9% 67 / 39
    ESCORTS 86 77 -10.9% 157 / 73
    HINDUJA TMT 386 344 -10.9% 890 / 332
    PUNJAB TRACTORS 247 223 -9.6% 359 / 218
    IGATE GLOBAL 235 214 -8.9% 432 / 165

    Pharma stocks closed mixed for the week with Glenmark Pharma (ended 5% up) and Wockhardt (up 3%) featuring among the major gainers, while Cipla (down 7%) and Panacea Biotech (down 5%) ended in the red. According to a leading business daily, the Monopolies and Restrictive Trade Practices Commission (MRTPC) has asked its investigation wing to probe a US-based NGO's allegation that pharma major Cipla is selling a crucial AIDS drug in Africa at a price, which is significantly less than the price for which it sold in India. Cipla has denied the allegation, saying it does not sell 'Viraday', a combination of three drugs, in Africa. The commission took note of the recent advertisements by the AIDS Healthcare Foundation, which said that the Cipla brand is available to a patient in Africa for Rs 21,200 for a year's treatment while it costs Rs 54,000 in India. It has asked the director-general of investigation and registration (DGIR) to find out the facts from the NGO and Cipla. While MRTPC is not a price regulator, it intervenes where it feels there is an unfair trade practice.

    While the markets did end in the positive, the gains were far from convincing. Not surprising, especially given the fact that even at current levels, most of the stocks look adequately valued from a medium term perspective. Thus, with the liquidity tap also being turned off to a great extent, courtesy the recent sub prime meltdown, more sanity is likely to prevail. As for investors, stay invested for the long-term and in good quality stocks as the India story very much remains intact.



    Equitymaster requests your view! Post a comment on "Volatile week". Click here!


    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    Were You Lured By Mr Market's Bait? (The 5 Minute Wrapup)

    Aug 23, 2017

    Mr Market lured investors into believing they'd bitten into a crash. Did you take the bait?

    Deep State First (Vivek Kaul's Diary)

    Aug 23, 2017

    Nowhere was the darkness deeper than in the nation's capital. There, no light shone. No flicker of awareness...observation...learning...or reflection appeared.

    Why Hasn't Warren Buffett Rung the Bell Yet? (The 5 Minute Wrapup)

    Aug 22, 2017

    It's surprising Warren Buffett hasn't warned investors about the expensive stock market? Let us know why.

    Think Twice Before You Keep Money In A Savings Bank Account (Outside View)

    Aug 22, 2017

    Post demonetisation, a cut in bank savings deposits rates was in the offing.

    More Views on News

    Most Popular

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

    Aug 10, 2017

    Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

    It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

    Aug 16, 2017

    The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 23, 2017 03:36 PM